Article
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
Cancer cell - 1 Oct 2007
Berns Katrien, Horlings Hugo M, Hennessy Bryan T, Madiredjo Mandy, Hijmans E Marielle, Beelen Karin, Linn Sabine C, Gonzalez-Angulo Ana Maria, Stemke-Hale Katherine, Hauptmann Michael, Beijersbergen Roderick L, Mills Gordon B, van de Vijver Marc J, Bernards René
Abstract excerpt
A large-scale RNA interference screen to discover genes involved in trastuzumab resistance in breast cancer identified only PTEN as a modulator of drug sensitivity. Oncogenic mutants of PIK3CA (activator of the same pathway and frequently mutated in breast cancer) also conferred resistance to trastuzumab in cell culture. In a cohort of 55 breast cancer patients, activation of the PI3K pathway, as judged by the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
